The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transcriptional profiling of matched biopsies reveals molecular determinants of enzalutamide resistance.
 
Thomas Westbrook
No Relationships to Disclose
 
Xiangnan Guan
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Aaron M. Udager
No Relationships to Disclose
 
Michael Haffner
No Relationships to Disclose
 
Tomasz M. Beer
Stock and Other Ownership Interests - Arvinas; Salarius Pharmaceuticals
Consulting or Advisory Role - Abbvie; Amgen; Arvinas; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Constellation Pharmaceuticals; Dantari Pharmaceuticals; GlaxoSmithKline; GRAIL; Janssen; Myovant Sciences; Pfizer; Sanofi; Sapience Therapeutics
Research Funding - Alliance Foundation Trials (Inst); Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Freenome (Inst); GRAIL (Inst); Harpoon Therapeutics (Inst); Janssen Research & Development (Inst); Medivation (Inst); Sotio (Inst); Theraclone Sciences (Inst); Zenith Epigenetics (Inst)
 
Rahul Raj Aggarwal
Honoraria - Clovis Oncology
Consulting or Advisory Role - Advanced Accelerator Applications; Alessa Therapeutics; Alessa Therapeutics; Amgen; AstraZeneca; Axiom Biotechnologies; Clovis Oncology; Dendreon; Jubilant Pharmaceuticals; Merck; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BioXCel therapeutics (Inst); Cancer Targeted Technology (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
 
Charles J. Ryan
Honoraria - Bayer; Janssen Oncology
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Clovis Oncology (Inst); Dendreon; Myovant Sciences; Roivant
Research Funding - Clovis Oncology (Inst); Genzyme (Inst)
 
Martin Gleave
Stock and Other Ownership Interests - Sitka; Sustained Therapeutics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Roche; Sanofi; Tersera
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Roche; Sanofi; Tersera
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427; Sitka - preclinical company focused on novel formulations of taxanes as intravesical agents for superficial bladder cancer; ST-CP; ST-POP
 
Jiaoti Huang
Stock and Other Ownership Interests - Gencode; Genetron Health; KingMed Diagnostics; More Health; Omnitura; Optra SCAN; Sisu Pharmaceuticals; VetOncoRx; York Biotechnology
Honoraria - Abbvie; Genetron Health; KingMed Diagnostics
Consulting or Advisory Role - Gem Flower Healthcare
Research Funding - BioXcell; Fortis; Zenith Epigenetics
Travel, Accommodations, Expenses - Gem Flower Healthcare (I)
 
Christopher P. Evans
Stock and Other Ownership Interests - Exelixis
Consulting or Advisory Role - Astellas Pharma; Pfizer
Speakers' Bureau - Janssen Biotech; Myovant Sciences; Pfizer
Research Funding - Anchiano (Inst); Astellas Pharma (Inst); Janssen Research & Development (Inst); Pfizer (Inst)
 
Robert Evan Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Bayer Schering Pharma; Genomic Health; ImaginAb; Janssen Oncology
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Owen Witte
Leadership - Allogene Therapeutics
Stock and Other Ownership Interests - 76Bio; Allogene Therapeutics; Appia Bio; IconOVir Bio; Kronos; Nammi Therapeutics; Neogene Therapeutics; SOFIE; Trethera; Vida Ventures
Honoraria - Allogene Therapeutics; IconOVir Bio; Kronos; Vida Ventures
Consulting or Advisory Role - 76Bio; Allogene Therapeutics; IconOVir Bio; Kronos; Vida Ventures
Travel, Accommodations, Expenses - Allogene Therapeutics
 
Matthew Rettig
Stock and Other Ownership Interests - ARavalent; Oncovalent Therapeutics; Survalent
Consulting or Advisory Role - Ambrx; Amgen; Clovis Oncology; Roivant
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
Josh Stuart
Employment - NantHealth
Stock and Other Ownership Interests - NantHealth
Patents, Royalties, Other Intellectual Property - NantHealth
 
George V. Thomas
Consulting or Advisory Role - Auron Therapeutics; Cygnal Therapeutics; Grail
Patents, Royalties, Other Intellectual Property - Patents to UCLA and OHSU (Inst)
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen; Johnson and Johnson
Consulting or Advisory Role - Fortis; Fortis; Janssen Oncology; Teon Therapeutics; Ultragenyx Pharmaceuticals
Travel, Accommodations, Expenses - Janssen
 
Joel Yates
Research Funding - Beactica
 
Zheng Xia
No Relationships to Disclose
 
Joshi J. Alumkal
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene
Research Funding - Beactica (Inst); Zenith Epigenetics (Inst)